Average Co-Inventor Count = 5.43
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (28 from 3,222 patents)
2. Seattle Genetics, Inc. (4 from 132 patents)
3. F. Hoffmann-la Roche Ag (1 from 168 patents)
4. Genetech, Inc. (1 from 98 patents)
5. Genenech, Inc. (1 from 1 patent)
6. Genoptera, LLC (1 from 1 patent)
7. Seagen Inc. (64 patents)
36 patents:
1. 11732054 - Anti-CD3 antibodies and methods of use
2. 11530275 - Anti-CD3 antibodies and methods of use
3. 11466087 - Anti-CLL-1 antibodies and methods of use
4. 11352431 - Anti-FCRH5 antibodies
5. 11186650 - Anti-CD3 antibodies and methods of use
6. 10941199 - Anti-CD79b antibodies and methods of use
7. 10865251 - Anti-CD3 antibodies and methods of use
8. 10640572 - Anti-CD3 antibodies and methods of use
9. 10501545 - Anti-CLL-1 antibodies and methods of use
10. 10435471 - Anti-FcRH5 antibodies
11. 10174124 - Anti-CD3 antibodies and methods of use
12. 9975949 - Anti-CD79b antibodies and methods of use
13. 9360484 - Anti-FcRH5 antibodies and immunoconjugates and methods of use
14. 9335320 - Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
15. 9085630 - Compositions and methods for the treatment of tumor of hematopoietic origin